Ravulizumab: Characterization and quantitation of a new C5 inhibitor using isotype specific affinity purification and high-resolution mass spectrometry

por Ladwig, Paula M., Willrich, Maria A.V.
Publicado 2021

Clinical Utility and Potential Cost Savings of Pharmacologic Monitoring of Eculizumab for Complement-Mediated Thrombotic Microangiopathy

por Sridharan, Meera, Go, Ronald S., Willrich, Maria A.V.
Publicado 2022

Mass Spectrometry Approaches for Identification and Quantitation of Therapeutic Monoclonal Antibodies in the Clinical Laboratory

por Ladwig, Paula M., Barnidge, David R., Willrich, Maria A. V.
Publicado 2017

MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients

por Mellors, Patrick W., Dasari, Surendra, Kohlhagen, Mindy C., Kourelis, Taxiarchis, Go, Ronald S., Muchtar, Eli, Gertz, Morie A., Kumar, Shaji K., Buadi, Francis. K., Willrich, Maria A. V., Lust, John A., Kapoor, Prashant, Lacy, Martha Q., Dingli, David, Hwa, Yi, Fonder, Amie, Hobbs, Miriam, Hayman, Susan, Warsame, Rahma, Leung, Nelson R., Lin, Yi, Gonsalves, Wilson, Siddiqui, Mustaqeem, Kyle, Robert A., Rajkumar, S. Vincent, Murray, David L., Dispenzieri, Angela
Publicado 2021

Correction: MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients

por Mellors, Patrick W., Dasari, Surendra, Kohlhagen, Mindy C., Kourelis, Taxiarchis, Go, Ronald S., Muchtar, Eli, Gertz, Morie A., Kumar, Shaji K., Buadi, Francis. K., Willrich, Maria A. V., Lust, John A., Kapoor, Prashant, Lacy, Martha Q., Dingli, David, Hwa, Yi, Fonder, Amie, Hobbs, Miriam, Hayman, Susan, Warsame, Rahma, Leung, Nelson R., Lin, Yi, Gonsalves, Wilson, Siddiqui, Mustaqeem, Kyle, Robert A., Rajkumar, S. Vincent, Murray, David L., Dispenzieri, Angela
Publicado 2021